Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1164 per EA under NDC 24979072706. Its NADAC has been published 85 times since Jan 8, 2025.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979072706
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA210420FDA Approved
3/26/2019
TE Code
AB1
On Market Since
4/7/2024
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 85 times since Jan 8, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1164 per EA |
|---|---|
| All-time high | $0.1376 (May 14, 2025) |
| All-time low | $0.1106 (Jan 22, 2025) |
| 52-week high | $0.1298 |
| 52-week low | $0.1143 |
| Median price | $0.1225 |
| Average price | $0.1232 |
| Largest weekly change | +9.7% (Mar 19, 2025) |
| Weeks tracked | 85 |
| Tracking since | Jan 8, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1164 per EA (NDC 24979072706), effective Aug 19, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 85 weekly CMS publications since Jan 8, 2025.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Jan 8, 2025, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.1106 (Jan 22, 2025) to a high of $0.1376 (May 14, 2025), with a median of $0.1225 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 3% below TADALAFIL 2.5 MG TABLET.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 24979072706) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.